Data from the real-world STEER study, presented Friday at the 2025 European Society of Cardiology Congress, showed that Wegovy treatment resulted in a 57% lower likelihood of heart attack and stroke, as well as cardiovascular death and death from any cause, versus tirzepatide
- Pruijm M et al, Kidney International 2025 This was announced at Kidney Week 2025, and we can expect exciting publications to come from this unique trial design to come out during 2026 and beyond
Does GHK-Cu build up tolerance over time
Saccharomyces boulardii, a probiotic yeast, shows particular promise for medication-induced diarrhea
For this user, semaglutide worked wonders to improve their eating habits, and their body adjusted pretty well to the drug, given that they experienced only minimal, manageable side effects